Bill Sponsor
BILLSPONSOR
Bill Sponsor
Politicians
Bills
House Simple Resolution 700
118th Congress(2023-2024)
Expressing support for the designation of September 2023 as "National Prostate Cancer Awareness Month".
Introduced
Introduced
Introduced in House on Sep 19, 2023
Overview
Text
Introduced in House 
Sep 19, 2023
No Linkage Found
About Linkage
Multiple bills can contain the same text. This could be an identical bill in the opposite chamber or a smaller bill with a section embedded in a larger bill.
Bill Sponsor regularly scans bill texts to find sections that are contained in other bill texts. When a matching section is found, the bills containing that section can be viewed by clicking "View Bills" within the bill text section.
Bill Sponsor is currently only finding exact word-for-word section matches. In a future release, partial matches will be included.
Introduced in House(Sep 19, 2023)
Sep 19, 2023
No Linkage Found
About Linkage
Multiple bills can contain the same text. This could be an identical bill in the opposite chamber or a smaller bill with a section embedded in a larger bill.
Bill Sponsor regularly scans bill texts to find sections that are contained in other bill texts. When a matching section is found, the bills containing that section can be viewed by clicking "View Bills" within the bill text section.
Bill Sponsor is currently only finding exact word-for-word section matches. In a future release, partial matches will be included.
Jump To
H. RES. 700 (Introduced-in-House)


118th CONGRESS
1st Session
H. RES. 700


Expressing support for the designation of September 2023 as “National Prostate Cancer Awareness Month”.

IN THE HOUSE OF REPRESENTATIVES

September 19, 2023

Mr. Payne (for himself, Mr. Fitzpatrick, Ms. Adams, Ms. Crockett, Mr. Jackson of Illinois, Mr. Meeks, Mr. Carter of Louisiana, Mr. Bacon, Mr. Veasey, Mr. Davis of North Carolina, Ms. Clarke of New York, Mr. Carson, Ms. Williams of Georgia, Mr. Grijalva, Mr. Hunt, Mr. Johnson of Georgia, Mr. Dunn of Florida, Mr. Lieu, Mr. Grothman, Mr. Menendez, Mr. Valadao, Mr. Westerman, Ms. Caraveo, and Mr. Bishop of Georgia) submitted the following resolution; which was referred to the Committee on Energy and Commerce

RESOLUTION

Expressing support for the designation of September 2023 as “National Prostate Cancer Awareness Month”.

    Whereas more than 3,100,000 men have at some point been diagnosed with prostate cancer and are still alive in the United States;

    Whereas 1 in 8 men in the United States will be diagnosed with prostate cancer in their lifetimes and 1 in 41 men in the United States will die from prostate cancer;

    Whereas prostate cancer is the most commonly diagnosed nonskin cancer and the second-leading cause of cancer-related deaths among men in the United States;

    Whereas the American Cancer Society estimates that, in 2023, 288,300 men will be diagnosed with, and more than 34,700 men will die of, prostate cancer;

    Whereas 40 percent of newly diagnosed prostate cancer cases occur in men under the age of 65;

    Whereas the odds of developing prostate cancer rise rapidly after age 50;

    Whereas African-American men suffer from a prostate cancer incidence rate that is significantly higher than that of White men and have more than double the prostate cancer mortality rate than that of White men;

    Whereas having a father or brother with prostate cancer more than doubles the risk of a man developing prostate cancer, with a higher risk for men who have a brother with the disease and the highest risk for men with several affected relatives;

    Whereas screening by a digital rectal examination and a prostate-specific antigen blood test can detect the disease at the earlier, more treatable stages, which could increase the chances of survival for more than 5 years to nearly 100 percent;

    Whereas only 32 percent of men survive more than 5 years if diagnosed with prostate cancer after the cancer has metastasized;

    Whereas there are typically no noticeable symptoms of prostate cancer in the early stages, making appropriate screening critical;

    Whereas, in fiscal year 2023, Congress appropriated $47,500,000,000 to the National Institutes of Health, including $7,104,159,000 for the National Cancer Institute;

    Whereas, in fiscal year 2023, Congress appropriated $110,000,000 for the peer-reviewed Prostate Cancer Research Program of the Department of Defense;

    Whereas the Department of Veterans Affairs has established 21 Precision Oncology Centers of Excellence in order to deliver precision oncology services to veterans suffering from prostate cancer;

    Whereas ongoing research promises further improvements in prostate cancer prevention, early detection, and treatment; and

    Whereas educating people in the United States, including health care providers, about prostate cancer and early detection strategies is crucial to saving the lives of men and preserving and protecting families: Now, therefore, be it

Resolved,

That the House of Representatives—

(1) expresses support for the designation of “National Prostate Cancer Awareness Month”;

(2) declares that steps should be taken—

(A) to raise awareness about the importance of screening methods for, and treatment of, prostate cancer;

(B) to encourage research—

(i) to improve screening and treatment for prostate cancer;

(ii) to discover the causes of prostate cancer; and

(iii) to develop a cure for prostate cancer; and

(C) to continue to consider ways to improve access to, and the quality of, health care services for detecting and treating prostate cancer; and

(3) calls on the people of the United States, interest groups, and affected persons—

(A) to promote awareness of prostate cancer;

(B) to take an active role in the fight to end the devastating effects of prostate cancer on individuals, families, and the economy; and

(C) to observe National Prostate Cancer Awareness Month with appropriate ceremonies and activities.